MODULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF HUMAN MONOCYTES BY IGA

被引:25
作者
JANOFF, EN
WAHL, SM
THOMAS, K
SMITH, PD
机构
[1] NIDR,IMMUNOL LAB,BETHESDA,MD 20892
[2] UNIV ALABAMA,DEPT MED,DIV GASTROENTEROL & HEPATOL,BIRMINGHAM,AL
关键词
D O I
10.1093/infdis/172.3.855
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of IgA from human immunodeficiency virus type 1 (HIV-1)-infected patients on infection of primary human blood monocytes with the monocyte-tropic strain HIV-1(Bal) was evaluated in vitro. Preincubation of HIV-1(Bal) with purified serum IgA from 6 of 14 patients but from none of 5 seronegative subjects caused a >50% increase in reverse transcriptase activity. This increase was inhibited by preincubation of monocytes with nonimmune IgA, suggesting a role for Fccu receptors. Results were independent of CD4 T cell number and clinical stage. The IgA-mediated enhancement extended to more biologically relevant human mononuclear cells isolated from the intestinal lamina propria. The ability of serum IgA to enhance HIV-1 infection may be relevant to infection of both circulating monocytes and mucosal macrophages. These studies suggest the need to characterize the complex contribution of IgA and the mucosal immune system in promoting and preventing primary HIV-1 infection.
引用
收藏
页码:855 / 858
页数:4
相关论文
共 15 条
[1]  
BURKE DS, 1992, PERSPECT BIOL MED, V35, P511
[2]  
BURNETT PR, 1994, J IMMUNOL, V152, P4642
[3]   STUDIES OF ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INFECTION MEDIATED BY FC-RECEPTORS USING SERA FROM RECIPIENTS OF A RECOMBINANT GP160 EXPERIMENTAL HIV-1 VACCINE [J].
HAUBRICH, RH ;
TAKEDA, A ;
KOFF, W ;
SMITH, G ;
ENNIS, FA .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :545-548
[4]   THE FC AND NOT CD4 RECEPTOR MEDIATES ANTIBODY ENHANCEMENT OF HIV INFECTION IN HUMAN-CELLS [J].
HOMSY, J ;
MEYER, M ;
TATENO, M ;
CLARKSON, S ;
LEVY, JA .
SCIENCE, 1989, 244 (4910) :1357-1360
[5]   INTESTINAL MUCOSAL IMMUNOGLOBULINS DURING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
JANOFF, EN ;
JACKSON, S ;
WAHL, SM ;
THOMAS, K ;
PETERMAN, JH ;
SMITH, PD .
JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (02) :299-307
[6]   SERUM IGA SUBCLASSES AND MOLECULAR-FORMS IN HIV-INFECTION - SELECTIVE INCREASES IN MONOMER AND APPARENT RESTRICTION OF THE ANTIBODY-RESPONSE TO IGA1 ANTIBODIES MAINLY DIRECTED AT ENV GLYCOPROTEINS [J].
KOZLOWSKI, PA ;
JACKSON, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (10) :1773-1780
[7]   CONTRASTING IGA AND IGG NEUTRALIZATION CAPACITIES AND RESPONSES TO HIV TYPE-1 GP120 V3 LOOP IN HIV-INFECTED INDIVIDUALS [J].
KOZLOWSKI, PA ;
CHEN, DX ;
ELDRIDGE, JH ;
JACKSON, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) :813-822
[8]   ANTIBODY-DEPENDENT ENHANCEMENT OF INFECTION AND THE PATHOGENESIS OF VIRAL DISEASE [J].
MORENS, DM .
CLINICAL INFECTIOUS DISEASES, 1994, 19 (03) :500-512
[9]  
PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508
[10]   ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION INVITRO BY SERUM FROM HIV-1-INFECTED AND PASSIVELY IMMUNIZED CHIMPANZEES [J].
ROBINSON, WE ;
MONTEFIORI, DC ;
MITCHELL, WM ;
PRINCE, AM ;
ALTER, HJ ;
DREESMAN, GR ;
EICHBERG, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (12) :4710-4714